Plasma coagulation factors and other plasma proteins

Plasma coagulation factors and other plasma proteins represent a broad category of essential blood components responsible for hemostasis, transport, and the maintenance of osmotic pressure (StatPearls: NBK507795). The coagulation factors, primarily serine proteases and cofactors, function in a highly regulated cascade to generate thrombin, which converts fibrinogen into a stable fibrin clot (NIH: NBK226). Other plasma proteins, such as albumin, serve as the primary determinants of plasma oncotic pressure and act as carriers for hormones, fatty acids, and drugs (PubMed: 30164451). Pathological imbalances in these proteins can lead to life-threatening conditions, including spontaneous hemorrhage in hemophilia or pathological clot formation in deep vein thrombosis and pulmonary embolism (Mayo Clinic, 2023). Therapeutic strategies targeting this group include anticoagulants to prevent stroke and thrombosis, procoagulants to manage bleeding, and plasma volume expanders or specific protein replacements for deficiency states (DrugBank: DBCAT000114). This entry is marked as incorrect because it describes a collective group of proteins rather than a single molecular target.

Other names

Blood clotting factorsCoagulation cascade proteinsPlasma proteinsHemostatic factorsSerum proteins

Drugs targeting this group act through several mechanisms: direct inhibition of specific serine proteases like Factor Xa or Thrombin (e.g., DOACs), antagonism of Vitamin K-dependent gamma-carboxylation (e.g., Warfarin), potentiation of endogenous anticoagulants like Antithrombin III (e.g., Heparin), or direct replacement of deficient proteins in genetic or acquired deficiency states (e.g., Factor VIII for Hemophilia A).